Your browser doesn't support javascript.
loading
Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemic.
Kinloch, Natalie N; MacMillan, Daniel R; Le, Anh Q; Cotton, Laura A; Bangsberg, David R; Buchbinder, Susan; Carrington, Mary; Fuchs, Jonathan; Harrigan, P Richard; Koblin, Beryl; Kushel, Margot; Markowitz, Martin; Mayer, Kenneth; Milloy, M J; Schechter, Martin T; Wagner, Theresa; Walker, Bruce D; Carlson, Jonathan M; Poon, Art F Y; Brumme, Zabrina L.
Afiliación
  • Kinloch NN; Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
  • MacMillan DR; Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
  • Le AQ; Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
  • Cotton LA; Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
  • Bangsberg DR; Massachusetts General Hospital, Boston, Massachusetts, USA Harvard Medical School, Cambridge, Massachusetts, USA.
  • Buchbinder S; San Francisco Department of Public Health, San Francisco, California, USA University of California, San Francisco, San Francisco, California, USA.
  • Carrington M; Cancer and Inflammation Program, Laboratory of Experimental Immunology, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA Ragon Institute of Massachusetts General Hospital, MIT, and Harvard University, Cambridge, Massachusetts, USA.
  • Fuchs J; San Francisco Department of Public Health, San Francisco, California, USA University of California, San Francisco, San Francisco, California, USA.
  • Harrigan PR; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Koblin B; New York Blood Center, New York, New York, USA.
  • Kushel M; University of California, San Francisco, San Francisco, California, USA.
  • Markowitz M; Aaron Diamond AIDS Research Center, New York, New York, USA.
  • Mayer K; Harvard Medical School, Cambridge, Massachusetts, USA Fenway Community Health, Boston, Massachusetts, USA.
  • Milloy MJ; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Schechter MT; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Wagner T; San Francisco Department of Public Health, San Francisco, California, USA.
  • Walker BD; Ragon Institute of Massachusetts General Hospital, MIT, and Harvard University, Cambridge, Massachusetts, USA.
  • Carlson JM; Microsoft Research, Seattle, Washington, USA.
  • Poon AF; Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Brumme ZL; Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada zbrumme@sfu.ca.
J Virol ; 90(3): 1244-58, 2016 02 01.
Article en En | MEDLINE | ID: mdl-26559841
ABSTRACT
UNLABELLED Human leukocyte antigen (HLA) class I-associated polymorphisms in HIV-1 that persist upon transmission to HLA-mismatched hosts may spread in the population as the epidemic progresses. Transmission of HIV-1 sequences containing such adaptations may undermine cellular immune responses to the incoming virus in future hosts. Building upon previous work, we investigated the extent of HLA-associated polymorphism accumulation in HIV-1 polymerase (Pol) through comparative analysis of linked HIV-1/HLA class I genotypes sampled during historic (1979 to 1989; n = 338) and modern (2001 to 2011; n = 278) eras from across North America (Vancouver, BC, Canada; Boston, MA; New York, NY; and San Francisco, CA). Phylogenies inferred from historic and modern HIV-1 Pol sequences were star-like in shape, with an inferred most recent common ancestor (epidemic founder virus) sequence nearly identical to the modern North American subtype B consensus sequence. Nevertheless, modern HIV-1 Pol sequences exhibited roughly 2-fold-higher patristic (tip-to-tip) genetic distances than historic sequences, with HLA pressures likely driving ongoing diversification. Moreover, the frequencies of published HLA-associated polymorphisms in individuals lacking the selecting HLA class I allele was on average ∼2.5-fold higher in the modern than in the historic era, supporting their spread in circulation, though some remained stable in frequency during this time. Notably, polymorphisms restricted by protective HLA alleles appear to be spreading to a greater relative extent than others, though these increases are generally of modest absolute magnitude. However, despite evidence of polymorphism spread, North American hosts generally remain at relatively low risk of acquiring an HIV-1 polymerase sequence substantially preadapted to their HLA profiles, even in the present era. IMPORTANCE HLA class I-restricted cytotoxic T-lymphocyte (CTL) escape mutations in HIV-1 that persist upon transmission may accumulate in circulation over time, potentially undermining host antiviral immunity to the transmitted viral strain. We studied >600 experimentally collected HIV-1 polymerase sequences linked to host HLA information dating back to 1979, along with phylogenetically reconstructed HIV-1 sequences dating back to the virus' introduction into North America. Overall, our results support the gradual spread of many-though not all-HIV-1 polymerase immune escape mutations in circulation over time. This is consistent with recent observations from other global regions, though the extent of polymorphism accumulation in North America appears to be lower than in populations with high seroprevalence, older epidemics, and/or limited HLA diversity. Importantly, the risk of acquiring an HIV-1 polymerase sequence at transmission that is substantially preadapted to one's HLA profile remains relatively low in North America, even in the present era.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Variación Genética / Adaptación Biológica / Antígenos de Histocompatibilidad Clase I / Infecciones por VIH / VIH-1 / Productos del Gen pol del Virus de la Inmunodeficiencia Humana Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies País/Región como asunto: America do norte Idioma: En Revista: J Virol Año: 2016 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Variación Genética / Adaptación Biológica / Antígenos de Histocompatibilidad Clase I / Infecciones por VIH / VIH-1 / Productos del Gen pol del Virus de la Inmunodeficiencia Humana Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies País/Región como asunto: America do norte Idioma: En Revista: J Virol Año: 2016 Tipo del documento: Article